PGNY's Quality Score fell 1 point on Tue, Nov 10, to 20. Trading went back to normal after a busy day.
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Up 31% from Oct 27 to Nov 10.
| Sales up 64% | $786.9M → $1.29B in 3 years |
| Its score | Up:Up to Exceptional for the first time since Feb 2024 |
| Latest filing | 10-Q, Nov 5 |
After its last 4 reports it closed +2.6% on average, higher 2 of 4 times.
Exceptionalfor quality, not price, 8 of 14 chart checks firingWhat the Quality Score means
Well above its recent run. PGNY scores 20 today, against a median of 12 over its last 20 recorded sessions.
PGNY is #1 of 5 by Quality Score.
| Rank | Stock | Quality Score |
|---|---|---|
| 1 | ||
| 2 | ||
| 3 | ||
| Open for its score | ||
| Open for its score |
Expected to report Thu Feb 25, after the close (in 107 days).
What an earnings report is: every 3 months, a company tells everyone how much it sold and earned. We read the figures, the outlook, and how the stock moved after.
Sales of $341.3M, 9% more than a year ago; a profit of $0.32 a share, from $0.15.
“We achieved strong top- and bottom-line growth this quarter, reflecting that member engagement was consistent with our expectations, and we are pleased to be in a position to raise the midpoint of our full year guidance,”
| Line | Q3 2026 | Q2 2026 | Q3 2025 |
|---|---|---|---|
| Fertility benefit services revenue | $223M | $230M | $202M |
Each quarter's sales and their share of its total. Figures as filed (SEC filing, Nov 5)
| Measure | Figure |
|---|---|
| Revenue | $1.365B to $1.385B |
Sales grew 30% a year over 5 years, fiscal 2020 to 2025.
Its share count fell 1.9% a year over 5 years.
| Reported | Gap | Reaction | 5 days |
|---|---|---|---|
| Nov 4, 2026 | +10.2% | +14.2% | not yet |
| Aug 6, 2026 | -15.4% | -7.0% | -14.3% |
| May 7, 2026 | +22.1% | +23.8% | +19.4% |
Sales grew every year from 2020 to 2025, to $1.3B. It made a profit in each of the six years.
RSI 83.1, MACD above signal, above both averages. Not scored.
3 insiders sold $694K across 4 filings in the last 6 months. No open-market buys on record. The newest:
One trade disclosed in the last six months. The newest:
Officers and directors with a Form 4 in the last 12 months.
In ETFs: PGNY is under 0.1% of VTI, the most of the 24 funds Breakaway covers, by their holdings as filed for Jun 30, 2026.
Progyny Inc is a benefits management company specializing in fertility, family building, and women's health benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments, and active management of the selective network of high-quality provider clinics.
“While we do not believe any single competitor offers a similarly robust, integrated fertility and family building benefits solution, there are alternative solutions in the market such as the health insurance companies who are able to provide fertility benefits management services as part of their overall administration of a company’s health plan and who are our primary competitors.”
PGNY scores 20 today, which Breakaway calls Exceptional. It is #1 of 5 in Services-Miscellaneous Health & Allied Services by Quality Score, with 8 of 14 chart checks firing. Up 31% from Oct 27 to Nov 10. Breakaway does not say whether to buy any stock: the score does not know your situation, and it is not a recommendation to buy or sell anything. Please do your own research.
PGNY scores 20 today, which Breakaway calls Exceptional (20 or more). That is #1 of 5 in Services-Miscellaneous Health & Allied Services by Quality Score. The score adds up the chart checks, the trend, the company's filed sales, its profits, the news, insider trades, and Congress trades. The section above lists the lines behind PGNY's 20.
3 insiders sold $694K across 4 filings in the last 6 months. No open-market buys on record. The newest is Kevin K. Gordon, Director, who sold $321K on Sep 10. Every filing, with the scored weight, for Pro members.
Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.
Insider and Congress trades, the chart, and the financials, in one score.
See it live, free until Thursday morning. No account. No card. Then keep going with a free account.